Literature DB >> 11880964

Shining light on "Dark Winter".

Tara O'Toole1, Michael Mair, Thomas V Inglesby.   

Abstract

On 22--23 June 2001, the Johns Hopkins Center for Civilian Biodefense Strategies, in collaboration with the Center for Strategic and International Studies, the Analytic Services Institute for Homeland Security, and the Oklahoma National Memorial Institute for the Prevention of Terrorism, held a senior-level exercise entitled "Dark Winter" that simulated a covert smallpox attack on the United States. The first such exercise of its kind, Dark Winter was constructed to examine the challenges that senior-level policy makers would face if confronted with a bioterrorist attack that initiated outbreaks of highly contagious disease. The exercise was intended to increase awareness of the scope and character of the threat posed by biological weapons among senior national security experts and to bring about actions that would improve prevention and response strategies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11880964     DOI: 10.1086/339909

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  27 in total

1.  Antiviral immunity following smallpox virus infection: a case-control study.

Authors:  Erika Hammarlund; Matthew W Lewis; Jon M Hanifin; Motomi Mori; Caroline W Koudelka; Mark K Slifka
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

2.  The quarantine war: the burning of the New York Marine Hospital in 1858.

Authors:  Kathryn Stephenson
Journal:  Public Health Rep       Date:  2004 Jan-Feb       Impact factor: 2.792

3.  Contacting passengers after exposure to measles on an international flight: Implications for responding to new disease threats and bioterrorism.

Authors:  Lara E Lasher; Tracy L Ayers; Pauli N Amornkul; Michele N Nakatab; Paul V Effler
Journal:  Public Health Rep       Date:  2004 Sep-Oct       Impact factor: 2.792

4.  Combination therapy of vaccinia virus infection with human anti-H3 and anti-B5 monoclonal antibodies in a small animal model.

Authors:  Megan M McCausland; Mohammed Rafii-El-Idrissi Benhnia; Lindsay Crickard; John Laudenslager; Steven W Granger; Tomoyuki Tahara; Ralph Kubo; Lilia Koriazova; Shinichiro Kato; Shane Crotty
Journal:  Antivir Ther       Date:  2010

5.  5-(Dimethoxymethyl)-2'-deoxyuridine: a novel gem diether nucleoside with anti-orthopoxvirus activity.

Authors:  Xuesen Fan; Xinying Zhang; Longhu Zhou; Kathy A Keith; Earl R Kern; Paul F Torrence
Journal:  J Med Chem       Date:  2006-06-01       Impact factor: 7.446

6.  Orthopoxvirus detection in environmental specimens during suspected bioterror attacks: inhibitory influences of common household products.

Authors:  Andreas Kurth; John Achenbach; Liljia Miller; Ian M Mackay; Georg Pauli; Andreas Nitsche
Journal:  Appl Environ Microbiol       Date:  2007-10-26       Impact factor: 4.792

7.  Legal tools for preparedness and response: variation in quarantine powers among the 10 most populous US states in 2004.

Authors:  Frederic E Shaw; Karen L McKie; Clint A Liveoak; Richard A Goodman
Journal:  Am J Public Health       Date:  2007-04-05       Impact factor: 9.308

8.  Population-based simulations of influenza pandemics: validity and significance for public health policy.

Authors:  Toomas Timpka; Henrik Eriksson; Elin A Gursky; James M Nyce; Magnus Morin; Johan Jenvald; Magnus Strömgren; Einar Holm; Joakim Ekberg
Journal:  Bull World Health Organ       Date:  2009-04       Impact factor: 9.408

9.  Issue a boil-water advisory or wait for definitive information? A decision analysis.

Authors:  Michael M Wagner; Garrick L Wallstrom; Agnieszka Onisko
Journal:  AMIA Annu Symp Proc       Date:  2005

10.  Collaboration between public health and law enforcement: new paradigms and partnerships for bioterrorism planning and response.

Authors:  Jay C Butler; Mitchell L Cohen; Cindy R Friedman; Robert M Scripp; Craig G Watz
Journal:  Emerg Infect Dis       Date:  2002-10       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.